Mr Mohammed Amine ZITOUNI | Biomaterials | Best Researcher Award

Published on by Material Scientist

Mr Mohammed Amine ZITOUNI | Biomaterials | Best Researcher Award

Mr. Mohammed Amine Zitouni is an Algerian researcher specializing in polymer chemistry and macromolecular organic chemistry. He was born on August 31, 1985, in Sabra, Tlemcen, Algeria. Currently pursuing a Ph.D. in Polymer Chemistry at the University of Tlemcen, he holds a strong academic foundation with a Magister degree and a postgraduate diploma in chemistry. Mr. Zitouni has engaged in both national and international scientific activities, including participation in major conferences across Algeria and Russia. His research focuses on novel hydrogel synthesis, polymeric drug delivery systems, and chitosan-based materials.

Mr Mohammed Amine ZITOUNI, Laboratory of Research on macromolecules, Department of Chemistry, Science Faculty, University of Tlemcen, Algeria

Profile

ORCID

🎓 Education

Mr. Mohammed Amine Zitouni has a strong academic foundation in chemistry and life sciences 📘🧪. He earned his Bachelor’s degree in Natural and Life Sciences in June 2003 🎓🌿. He then pursued a Postgraduate Diploma in Chemistry from the University of Tlemcen in September 2007 🧬🏫. In December 2010, he obtained a Magister’s degree specializing in Macromolecular Organic Chemistry and Physical Chemistry ⚗️📚. Currently, he is working toward a Ph.D. in Polymer Chemistry at the University of Tlemcen, focusing on advanced polymeric materials for biomedical applications 🔬📖. His education reflects a clear commitment to scientific advancement.

🌍 Scientific Activities

Mr. Mohammed Amine Zitouni has actively participated in national and international scientific forums 🌐. He presented at the 10th International Conference of the European Chitin Society in Russia and major Algerian conferences like the CIMPC’17 in Tlemcen and the National Seminar on Polymers in Bejaïa 🎤🧪. With one year in the university tutoring program and four years of teaching LMD ST practical work, he contributes to student development 🎓🧑‍🏫. His research led to international publications on chitosan/PVA hydrogels in Advanced Materials Research and Annales pharmaceutiques françaises, focusing on novel drug delivery systems 📄💊.

💻 Skills

Mr. Mohammed Amine Zitouni is a multilingual researcher with strong communication and technical skills 🌍🧠. He is a native Arabic speaker, and is proficient in reading and writing in French and English, including technical scientific English for academic and research purposes 📘📚. His language skills allow him to effectively engage with international research communities and contribute to global scientific discourse 🌐✍️. In addition, he possesses excellent computer skills, demonstrating a perfect command of software tools and digital platforms essential for scientific research, data analysis, and academic publishing 🧑‍💻📊.

🔬 Research Focus

Mr. Mohammed Amine Zitouni’s research focuses on the synthesis and characterization of biopolymer-based hydrogels for pharmaceutical applications 🧪💊. He develops advanced drug delivery systems using crosslinked chitosan and polyvinyl alcohol (PVA), aiming to enhance controlled release of antibiotics such as chlorotetracycline hydrochloride 🔄🧫. His work explores the physicochemical interactions within hydrogels to optimize stability, biocompatibility, and drug release efficiency 📈🧬. This research holds significant promise for medical treatments requiring sustained delivery mechanisms and aligns with sustainable, biodegradable material innovation 🌱🔍. His expertise contributes to the intersection of polymer science and biomedical engineering 🧠🏥.

📘 Publications

Preparation and characterization of hydrogels based on Chitosan/polyvinyl alcohol blends
Journal: Advanced Materials Research
Focus: Synthesis and structural analysis of biocompatible hydrogels for advanced material applications.
🧪💧

Release of Chlorotetracycline Hydrochloride From Novel Hydrogels Based On Crosslinked Chitosan And PVA
Journal: Annales Pharmaceutiques Françaises
Focus: Controlled drug release systems using crosslinked hydrogels for pharmaceutical applications.
💊🧬📗

Sailee Chowdhury | Biomaterials | Best Researcher Award

Published on by Material Scientist

Sailee Chowdhury | Biomaterials | Best Researcher Award

Prof Sailee Chowdhury, BCDA College of Pharmacy & Technology, India

Prof. Sailee Chowdhury is a distinguished academic and researcher in pharmaceutical technology with 17+ years of teaching experience 📚✨. She holds a Ph.D. in Pharmaceutical Technology and has over 11 years of postdoctoral research experience. Her work spans flavonoids, nanoparticles, tissue engineering, and sustainable practices in drug discovery 🌿🔬. Prof. Chowdhury has published extensively in reputed journals and authored several book chapters, showcasing her commitment to knowledge dissemination 📖. As Head of the Department, she leads with excellence in education and administration 🏫🎓. Her active role in conferences and institutional committees reflects her influence and dedication to research ethics and innovation 🌍💡.

Publication Profile

Scopus

Orcid

Educational Background 🎓

Prof. Sailee Chowdhury is a highly qualified academic with a Ph.D. in Pharmaceutical Technology from MAKAUT, Kolkata, awarded in 2013 🎓🔬. She holds an M.Pharm in Pharmaceutical Chemistry with First Class honors (SGPA 9) from Biju Pattnaik University of Technology (2006) 🧪📘 and qualified GATE in 2004 🎯. Her academic journey began with a B.Pharm degree (Honors) scoring 80.3% from Burdwan University in 2004, followed by stellar performances in Higher Secondary (68%, WBCHSE, 2000) and Madhyamik (87%, WBBSE, 1998) 📚🌟. Prof. Chowdhury’s consistent academic excellence forms the foundation of her illustrious career in pharmaceutical education and research 🌍📖.

Professional Experience and Contributions 💼

Prof. Sailee Chowdhury brings over 17 years of teaching experience at BCDA College of Pharmacy & Technology, Kolkata 🎓📘, where she has progressed through roles from Lecturer to Professor and currently serves as Head of the Department of Pharmaceutical Chemistry (since April 2022) 🧪🔬. Post-Ph.D., she has over 11 years of academic and research experience 🌟. She actively contributes to UG and PG education, administrative roles, NBA accreditation, and institutional committees 📊📜. A recognized academic leader, she has organized national and international seminars, served as a reviewer for reputed journals and books, and contributed extensively to pharmaceutical education 🌍💡.

Participation in Conference Seminar & Workshops 🌐

Prof. Sailee Chowdhury has actively participated in numerous national and international conferences, seminars, and workshops, serving in roles such as Joint Convenor, Evaluator, Co-chairperson, Chairperson, Panelist, and Advisory Member 🎤📚. Highlights include the 72nd Indian Pharmaceutical Congress in Nagpur, the International Conference on Drug Discovery at Brainware University 🌍💊, and multiple events organized by institutions like Jadavpur University and Amity University 🧪📖. She has chaired scientific sessions on medicinal plants and sustainable pharmaceutical practices, fostering academia-industry partnerships, and evaluating cutting-edge research, reflecting her commitment to advancing pharmaceutical education and research 🌱🔬.

Research Focus Area 🌱🧬

Prof. Sailee Chowdhury’s research spans pharmaceutical sciences, biomaterials, and sustainable innovation 🌿🔬. Her work includes the role of flavonoids and phenolics in gut microbiota modulation and combating metabolic diseases and biotic stress 🩺🍃. She advances enzymology in drug discovery 💊🧪, sustainable practices in the pharmaceutical industry 🌍⚗️, and plant-protein-based future foods 🌱🍽️. Her expertise extends to cutting-edge biomaterials, exploring nanoparticles for gene expression and osteoconductivity 🦴🧬, alginate biocomposites for drug delivery 🦠, and silk fibroin scaffolds for tissue engineering 🧵🏗️. This multidisciplinary focus aims to enhance healthcare, sustainability, and innovation, positioning her as a leader in pharmaceutical research. 🌟📘

Publication Top Notes📄✨

Flavonoids and their metabolites: Impact on gut microbiota in connection with chronic metabolic diseases

Phenolics as Shielding Counterparts from Plants to Combat Biotic Stress Mediated by Microbes and Nematodes

Enzymology in drug discovery

Sustainable Practices in the Pharmaceutical Industry: Development and Adoption

Applications of Modified Plant Protein-Based Future Foods

Nanoparticles for triggering gene expression and osteoconductivity

Biocomposites of Alginates in Drug Delivery

Silk Fibroin–Based Biomaterial Scaffold in Tissue Engineering: Present Persuasive Perspective

Conclusion

Prof. Sailee Chowdhury demonstrates a holistic profile of academic excellence, significant research contributions, and impactful teaching and leadership roles. These attributes strongly position her as a suitable nominee for the Best Researcher Award. Her focus on innovative and sustainable pharmaceutical practices adds further value to her candidacy.

Dalia Zaafar | Biomaterials | Women Researcher Award

Published on by Material Scientist

Dalia Zaafar | Biomaterials | Women Researcher Award

Assist. Prof. Dr Dalia Zaafar, Cairo University, Egypt

Dr. Dalia Zaafar is an Assistant Professor at Modern University for Technology and Information (MTI) in Egypt, specializing in pharmacology, toxicology, and clinical pharmacy. With a Ph.D. from Cairo University, she has led impactful research on cardiovascular pharmacology and oncology. 🌍 Her work includes clinical studies, focusing on metformin and sorafenib, contributing to drug safety. Dr. Zaafar is passionate about mentoring young researchers, especially women in academia, and has presented at international conferences. 🎓 She holds certifications in clinical practice and data analysis, enhancing her role as an expert in her field. 📚

Publication Profile

Google Scholar

Orcid

Scopus

Educational Background 🎓

Dr. Dalia Zaafar holds a Ph.D. in Pharmacology and Toxicology from Cairo University (2019), with a focus on clinical studies and cardiovascular pharmacology. Her dissertation explored the efficacy and safety of dipeptidyl peptidase inhibitors versus Metformin in diabetic hypertensive patients. 🎓 She earned an M.A. in Pharmacology and Toxicology from Suez Canal University (2014), specializing in oncology and endocrinology. Dr. Zaafar also completed a Clinical Pharmacy diploma (2019-2021) in critical care and further honed her skills through a Data Analysis Professional Nano-degree (2021) and other specialized certifications in clinical pharmacology and pharmacoeconomics. 📚💻

Current Role and Focus 💼

Dr. Dalia Zaafar is an Assistant Professor at the Modern University for Technology and Information (MTI), Egypt, where she has been teaching and conducting research since 2019. 🌟 She designs experimental studies, collaborates internationally, and mentors young researchers. Additionally, she serves on the editorial boards of the Universal Journal of Pharmaceutical Research and the World Journal of Clinical Cases. 📘 Previously, she worked as a Clinical Pharmacist in critical care at Teacher’s Hospital and Abu Sower Medical Center. Dr. Zaafar has expertise in clinical pharmacy, research supervision, and interdisciplinary initiatives, fostering academic growth and innovation. 🧪👩‍🏫

Participation in Conferences 🌐

Dr. Dalia Zaafar was a speaker at the 18th International Conference of Biochemistry and Molecular Biology, held on September 16-17, 2023. 🌍 Her lecture, titled “Unravelling the Complexities of Tau Protein Dysfunction in Alzheimer’s Disease: Pathophysiology, Biomarkers, and Therapeutic Perspectives”, highlighted groundbreaking insights into the mechanisms of Alzheimer’s disease. 🧠🔬 She discussed emerging biomarkers and innovative therapeutic strategies, contributing to a deeper understanding of this critical neurodegenerative condition. Dr. Zaafar’s presentation underscored her expertise in molecular biology and her dedication to advancing research for a better future for humanity. 🌟

Research Focus Area 🌱🧬

Dr. Dalia Zaafar’s research is focused on pharmacology, toxicology, and clinical pharmacy, with a multidisciplinary approach to tackling critical health challenges. 🧪 Her studies emphasize drug safety, cardiovascular pharmacology, and oncology, exploring innovative therapeutic interventions for diseases like Alzheimer’s, Parkinson’s, colon cancer, and drug-induced toxicities. 🔬 Her work integrates molecular biology, nanotechnology, and experimental pharmacology, addressing mechanisms like tumor angiogenesis, neuroprotection, and signal pathway modulation. 🌍 Dr. Zaafar’s impactful contributions also span natural product-based therapies, nanoparticles for drug delivery, and biomarker development, making her a pioneer in advancing personalized medicine and enhancing treatment efficacy. 🌟

Publication Top Notes📚🌐

Role of metformin in suppressing 1, 2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation

Hesperetin mitigates sorafenib-induced cardiotoxicity in mice through inhibition of the TLR4/NLRP3 signaling pathway

Selenium nanoparticles with prodigiosin rescue hippocampal damage associated with epileptic seizures induced by pentylenetetrazole in rats

Orexin pathway in Parkinson’s disease: a review

Discovery of new 1, 3, 4-oxadiazoles with dual activity targeting the cholinergic pathway as effective anti-Alzheimer agents

Comparing the effectiveness of L-carnitine and paraffin oil in acute aluminum phosphide poisoning using predictive biomarkers and scores: a randomized controlled clinical trial

Adherence to insulin therapy among children with type 1 diabetes: reliability and validity of the Arabic Version of the 4-Item Morisky Medication Adherence Scale

Combined β-sitosterol and trimetazidine mitigate potassium dichromate-induced cardiotoxicity in rats through the interplay between NF-κB/AMPK/mTOR/TLR4 and HO-1/NADPH signaling …

Salix subserrata Bark Extract–Loaded Chitosan Nanoparticles Attenuate Neurotoxicity Induced by Sodium Arsenate in Rats in Relation with HPLC–PDA-ESI–MS …

Conclusion 🔍

Dr. Dalia Zaafar’s dedication to research excellence, her leadership in mentoring young women researchers, and her impressive body of scholarly work make her a highly suitable candidate for the Women Researcher Award. Her contributions to pharmacology, particularly in clinical studies, and her active role in global research collaborations position her as an influential figure in the academic community.